Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

4.87
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
3.05
Today|||52-Week Range
10.90
-7.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues222.0K205.0K277.0K0.00
 
 
 
 
Depreciation And Amortization33.0K34.0K24.0K9.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------9.0K
 
 
General Expenses3.9M3.6M3.4M2.7M
 
 
 
 
 
Research And Development2.6M2.4M1.9M1.3M
 
 
 
 
 
Total Operating Expenses4.0M3.7M3.4M2.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.8M-3.5M-3.2M-2.7M
 
 
 
 
 
Other Expenses156.0K69.0K-86.0K820.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-3.4M-3.2M-1.9M
 
 
 
 
 
Income Taxes-626.0K-454.0K-410.0K-306.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Net Income-3.0M-2.9M-2.8M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M3.5M4.3M4.3M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M3.5M4.3M4.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.01-$0.86-$0.69-$0.38
 
 
 
 
 
EPS Diluted-$1.00-$0.86-$0.68-$0.38